Table of Contents Chapter 1 Overview of Cervical Cancer Diagnostic Testing Devices 1.1 Definition of Cervical Cancer Diagnostic Testing Devices in This Report 1.2 Commercial Types of Cervical Cancer Diagnostic Testing Devices 1.2.1 Cytopathological Method 1.2.2 Molecular Method 1.3 Downstream Application of Cervical Cancer Diagnostic Testing Devices 1.3.1 Hospitals 1.3.2 Clinical Diagnostic Laboratories 1.3.3 Homecare 1.3.4 Other 1.4 Development History of Cervical Cancer Diagnostic Testing Devices 1.5 Market Status and Trend of Cervical Cancer Diagnostic Testing Devices 2013-2023 1.5.1 EMEA Cervical Cancer Diagnostic Testing Devices Market Status and Trend 2013-2023 1.5.2 Regional Cervical Cancer Diagnostic Testing Devices Market Status and Trend 2013-2023 Chapter 2 EMEA Market Status and Forecast by Regions 2.1 Market Status of Cervical Cancer Diagnostic Testing Devices in EMEA 2013-2017 2.2 Consumption Market of Cervical Cancer Diagnostic Testing Devices in EMEA by Regions 2.2.1 Consumption Volume of Cervical Cancer Diagnostic Testing Devices in EMEA by Regions 2.2.2 Revenue of Cervical Cancer Diagnostic Testing Devices in EMEA by Regions 2.3 Market Analysis of Cervical Cancer Diagnostic Testing Devices in EMEA by Regions 2.3.1 Market Analysis of Cervical Cancer Diagnostic Testing Devices in Europe 2013-2017 2.3.2 Market Analysis of Cervical Cancer Diagnostic Testing Devices in Middle East 2013-2017 2.3.3 Market Analysis of Cervical Cancer Diagnostic Testing Devices in Africa 2013-2017 2.4 Market Development Forecast of Cervical Cancer Diagnostic Testing Devices in EMEA 2018-2023 2.4.1 Market Development Forecast of Cervical Cancer Diagnostic Testing Devices in EMEA 2018-2023 2.4.2 Market Development Forecast of Cervical Cancer Diagnostic Testing Devices by Regions 2018-2023 Chapter 3 EMEA Market Status and Forecast by Types 3.1 Whole EMEA Market Status by Types 3.1.1 Consumption Volume of Cervical Cancer Diagnostic Testing Devices in EMEA by Types 3.1.2 Revenue of Cervical Cancer Diagnostic Testing Devices in EMEA by Types 3.2 EMEA Market Status by Types in Major Countries 3.2.1 Market Status by Types in Europe 3.2.2 Market Status by Types in Middle East 3.2.3 Market Status by Types in Africa 3.3 Market Forecast of Cervical Cancer Diagnostic Testing Devices in EMEA by Types Chapter 4 EMEA Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Cervical Cancer Diagnostic Testing Devices in EMEA by Downstream Industry 4.2 Demand Volume of Cervical Cancer Diagnostic Testing Devices by Downstream Industry in Major Countries 4.2.1 Demand Volume of Cervical Cancer Diagnostic Testing Devices by Downstream Industry in Europe 4.2.2 Demand Volume of Cervical Cancer Diagnostic Testing Devices by Downstream Industry in Middle East 4.2.3 Demand Volume of Cervical Cancer Diagnostic Testing Devices by Downstream Industry in Africa 4.3 Market Forecast of Cervical Cancer Diagnostic Testing Devices in EMEA by Downstream Industry Chapter 5 Market Driving Factor Analysis of Cervical Cancer Diagnostic Testing Devices 5.1 EMEA Economy Situation and Trend Overview 5.2 Cervical Cancer Diagnostic Testing Devices Downstream Industry Situation and Trend Overview Chapter 6 Cervical Cancer Diagnostic Testing Devices Market Competition Status by Major Players in EMEA 6.1 Sales Volume of Cervical Cancer Diagnostic Testing Devices in EMEA by Major Players 6.2 Revenue of Cervical Cancer Diagnostic Testing Devices in EMEA by Major Players 6.3 Basic Information of Cervical Cancer Diagnostic Testing Devices by Major Players 6.3.1 Headquarters Location and Established Time of Cervical Cancer Diagnostic Testing Devices Major Players 6.3.2 Employees and Revenue Level of Cervical Cancer Diagnostic Testing Devices Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Cervical Cancer Diagnostic Testing Devices Major Manufacturers Introduction and Market Data 7.1 Abbott Laboratories 7.1.1 Company profile 7.1.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.1.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Abbott Laboratories 7.2 BD Medical 7.2.1 Company profile 7.2.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.2.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of BD Medical 7.3 Roche Molecular Diagnostics 7.3.1 Company profile 7.3.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.3.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Roche Molecular Diagnostics 7.4 Hologic 7.4.1 Company profile 7.4.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.4.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Hologic 7.5 Qiagen 7.5.1 Company profile 7.5.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.5.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Qiagen 7.6 Quest Diagnostics 7.6.1 Company profile 7.6.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.6.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Quest Diagnostics 7.7 BioMerieux 7.7.1 Company profile 7.7.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.7.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of BioMerieux 7.8 Cepheid 7.8.1 Company profile 7.8.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.8.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Cepheid 7.9 Arbor Vita 7.9.1 Company profile 7.9.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.9.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Arbor Vita 7.10 Trovagene 7.10.1 Company profile 7.10.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.10.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Trovagene 7.11 DAAN Gene 7.11.1 Company profile 7.11.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.11.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of DAAN Gene 7.12 Delphi Bioscience 7.12.1 Company profile 7.12.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.12.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Delphi Bioscience 7.13 Fujirebio Diagnostics 7.13.1 Company profile 7.13.2 Representative Cervical Cancer Diagnostic Testing Devices Product 7.13.3 Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Fujirebio Diagnostics Chapter 8 Upstream and Downstream Market Analysis of Cervical Cancer Diagnostic Testing Devices 8.1 Industry Chain of Cervical Cancer Diagnostic Testing Devices 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Cervical Cancer Diagnostic Testing Devices 9.1 Cost Structure Analysis of Cervical Cancer Diagnostic Testing Devices 9.2 Raw Materials Cost Analysis of Cervical Cancer Diagnostic Testing Devices 9.3 Labor Cost Analysis of Cervical Cancer Diagnostic Testing Devices 9.4 Manufacturing Expenses Analysis of Cervical Cancer Diagnostic Testing Devices Chapter 10 Marketing Status Analysis of Cervical Cancer Diagnostic Testing Devices 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Cytopathological Method Table Advantage and Disadvantage of Molecular Method Table Consumption Volume of Cervical Cancer Diagnostic Testing Devices in EMEA by Regions 2013-2017 Table Revenue of Cervical Cancer Diagnostic Testing Devices in EMEA by Regions 2013-2017 Table Consumption Volume of Cervical Cancer Diagnostic Testing Devices in EMEA by Regions 2018-2023 Table Revenue of Cervical Cancer Diagnostic Testing Devices in EMEA by Regions 2018-2023 Table Consumption Volume of Cervical Cancer Diagnostic Testing Devices in EMEA by Types 2013-2017 Table Revenue of Cervical Cancer Diagnostic Testing Devices in EMEA by Types 2013-2017 Table Consumption Volume of Cervical Cancer Diagnostic Testing Devices by Types in Europe 2013-2017 Table Consumption Volume of Cervical Cancer Diagnostic Testing Devices by Types in Middle East 2013-2017 Table Consumption Volume of Cervical Cancer Diagnostic Testing Devices by Types in Africa 2013-2017 Table Consumption Volume Forecast of Cervical Cancer Diagnostic Testing Devices in EMEA by Types 2018-2023 Table Revenue Forecast of Cervical Cancer Diagnostic Testing Devices in EMEA by Types 2018-2023 Table Demand Volume of Cervical Cancer Diagnostic Testing Devices in EMEA by Downstream Industry 2013-2017 Table Demand Volume of Cervical Cancer Diagnostic Testing Devices by Downstream Industry in Europe 2013-2017 Table Demand Volume of Cervical Cancer Diagnostic Testing Devices by Downstream Industry in Middle East 2013-2017 Table Demand Volume of Cervical Cancer Diagnostic Testing Devices by Downstream Industry in Africa 2013-2017 Table Demand Volume Forecast of Cervical Cancer Diagnostic Testing Devices in EMEA by Downstream Industry 2018-2023 Table Sales Volume of Cervical Cancer Diagnostic Testing Devices in EMEA by Major Players 2013-2017 Table Revenue of Cervical Cancer Diagnostic Testing Devices in EMEA by Major Players 2013-2017 Table Headquarters Location and Established Time of Cervical Cancer Diagnostic Testing Devices Major Players Table Employees and Revenue Level of Cervical Cancer Diagnostic Testing Devices Major Players Table Representative Cervical Cancer Diagnostic Testing Devices Product One of Abbott Laboratories Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of Abbott Laboratories Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Abbott Laboratories 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of BD Medical Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of BD Medical Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of BD Medical 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of Roche Molecular Diagnostics Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of Roche Molecular Diagnostics Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Roche Molecular Diagnostics 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of Hologic Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of Hologic Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Hologic 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of Qiagen Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of Qiagen Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Qiagen 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of Quest Diagnostics Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of Quest Diagnostics Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Quest Diagnostics 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of BioMerieux Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of BioMerieux Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of BioMerieux 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of Cepheid Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of Cepheid Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Cepheid 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of Arbor Vita Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of Arbor Vita Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Arbor Vita 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of Trovagene Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of Trovagene Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Trovagene 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of DAAN Gene Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of DAAN Gene Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of DAAN Gene 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of Delphi Bioscience Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of Delphi Bioscience Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Delphi Bioscience 2013-2017 Table Representative Cervical Cancer Diagnostic Testing Devices Product One of Fujirebio Diagnostics Table Representative Cervical Cancer Diagnostic Testing Devices Product Two of Fujirebio Diagnostics Table Cervical Cancer Diagnostic Testing Devices Sales, Revenue, Price and Gross Margin of Fujirebio Diagnostics 2013-2017